Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma.

The insulin-like growth factor (IGF) signaling pathway is an important pathway in the process of hepatocarcinogenesis, and the IGF network is clearly dysregulated in many cancers and developmental abnormalities. In hepatocellular carcinoma (HCC), only a minority of patients are eligible for curative treatments, such as tumor resection or liver transplant. Unfortunately, there is a high recurrence of HCC after surgical tumor removal. Recent research efforts have focused on targeting IGF axis members in an attempt to find therapeutic options for many health problems. In this review, we shed lights on the regulation of members of the IGF axis, mainly by microRNAs in HCC. MicroRNAs in HCC attempt to halt the aberrant expression of the IGF network, and a single microRNA can have multiple downstream targets in one or more signaling pathways. Targeting microRNAs is a relatively new approach for identifying an efficient radical cure for HCC.

• Publication year

  2016

• Venue

  World Journal of Gastroenterology

• Publication date

  2016-03-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3748/wjg.v22.i9.2668PMID 26973407PMCID PMC4777991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.

  2015cited by this paper
• Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma.

  2015cited by this paper
• P0316 : Despite repressing IGF-1R, miR-181A halts the tumor-suppressor activity of decorin by enhancing tumor progression in hepatocellular carcinoma

  2015cited by this paper
• P0482 : Improving natural killer cells cytotoxicty and harnessing hepatocyte cancer progression by MIR-486-5P

  2015cited by this paper
• Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma

  2014cited by this paper
• Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells

  2014cited by this paper
• 1097 HYPERMETHYLATION OF THE microRNA LET-7A-3 GENE REPRESSES THE PRIMARY AND MATURE LET-7A-3 WITH AN INVERSE CORRELATION TO IGF-II mRNA IN HCV-INDUCED HEPATOCELLULAR CARCINOMA

  2013cited by this paper
• Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern.

  2013cited by this paper
• MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.

  2012cited by this paper
• Epigenetic reprogramming during plant reproduction and seed development.

  2012cited by this paper
• miR‐615‐5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma

  2012cited by this paper
• 268 MIR-155 IS AN INDUCER FOR THE INSULIN-LIKE GROWTH FACTOR II MITOGENIC SIGNALING PATHWAY IN HCV-PROGRESSED HEPATOCELLULAR CARCINOMA

  2012cited by this paper
• Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients

  2011cited by this paper
• Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

  2011cited by this paper
• Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.

  2011cited by this paper
• Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells

  2011cited by this paper
• Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis

  2011cited by this paper
• Targeting insulin-like growth factor axis in hepatocellular carcinoma

  2011cited by this paper
• MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R

  2011cited by this paper
• MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma*

  2011cited by this paper
• Association of circulating insulin‐like growth factor 1 with hepatocellular carcinoma: one cross‐sectional correlation study

  2010cited by this paper
• Oncogenic role of miR-483-3p at the IGF2/483 locus.

  2010cited by this paper
• Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.

  2010cited by this paper
• A novel GSK‐3 beta–C/EBP alpha–miR‐122–insulin‐like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma

  2010cited by this paper
• The role of signaling pathways in the development and treatment of hepatocellular carcinoma

  2010cited by this paper
• Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction

  2010cited by this paper
• Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes.

  2008cited by this paper
• RNA‐binding protein insulin‐like growth factor II mRNA‐binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

  2008cited by this paper
• MiR-15a and miR-16-1 cluster functions in human leukemia

  2008cited by this paper
• DNA methylation landscapes: provocative insights from epigenomics

  2008cited by this paper
• The role of the IGF system in cancer growth and metastasis: overview and recent insights.

  2007cited by this paper
• Epigenetics and MicroRNAs

  2007cited by this paper
• Mannose 6-phosphate receptor targeting and its applications in human diseases.

  2007cited by this paper
• Epigenetics and MicroRNAs

  2007cited by this paper
• Cancer development and progression.

  2007cited by this paper
• Dysregulation of growth factor signaling in human hepatocellular carcinoma

  2006cited by this paper
• A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes.

  2006cited by this paper
• Intronic MicroRNA (miRNA)

  2006cited by this paper
• Implications of micro-RNA profiling for cancer diagnosis

  2006cited by this paper
• IGF1R signalling and its inhibition.

  2006cited by this paper
• Decitabine improves patient outcomes in myelodysplastic syndromes

  2006cited by this paper
• Pro- and mature IGF-II during diet-induced weight loss in obese subjects.

  2005cited by this paper
• The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes.

  2005cited by this paper
• Insulin-like growth factors and neoplasia

  2004cited by this paper
• An evaluation of new criteria for CpG islands in the human genome as gene markers

  2004cited by this paper
• An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.

  2004cited by this paper
• Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.

  2004cited by this paper
• MicroRNA genes are transcribed by RNA polymerase II

  2004cited by this paper
• Insulin-like growth factors and neoplasia.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Loss of parental‐specific methylation at the IGF2 locus in human hepatocellular carcinoma

  2003cited by this paper
• Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk

  2003cited by this paper
• Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.

  2003cited by this paper
• Loss of imprinting of IGF-II gene in children with acute lymphoblastic leukemia.

  2003cited by this paper
• Relaxation of Imprinting of IGFII gene in Juvenile Nasopharyngeal Angiofibromas

  2003cited by this paper
• The Human Dnmt2 Has Residual DNA-(Cytosine-C5) Methyltransferase Activity*

  2003cited by this paper
• A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.

  2003cited by this paper
• A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.

  2002cited by this paper
• Serum insulin‐like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus‐related cirrhosis

  2002cited by this paper
• IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms.

  2002cited by this paper
• DNA methylation patterns and epigenetic memory.

  2002cited by this paper
• Comprehensive analysis of CpG islands in human chromosomes 21 and 22

  2002cited by this paper
• Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation.

  2002cited by this paper
• Phosphatidylinositol 3-Kinase/Akt Stimulates Androgen Pathway through GSK3β Inhibition and Nuclear β-Catenin Accumulation*

  2002cited by this paper
• Decreased expression of the mannose 6- phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells

  2002cited by this paper
• The IGF axis and hepatocarcinogenesis

  2001cited by this paper
• Disturbed Synthesis of Insulinlike Growth Factor I and Its Binding Proteins May Influence Renal Function Changes in Liver Cirrhosis

  2001cited by this paper
• Changes in the relative abundance of mRNA transcripts for insulin-like growth factor (IGF-I and IGF-II) ligands and their receptors (IGF-IR/IGF-IIR) in preimplantation bovine embryos derived from different in vitro systems.

  2001cited by this paper
• Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras

  2000cited by this paper
• Role of the insulin-like growth factor family in cancer development and progression.

  2000cited by this paper
• Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells.

  1999cited by this paper
• Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9.

  1999cited by this paper
• A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development

  1999cited by this paper
• The insulin-like growth factor-binding protein (IGFBP) superfamily.

  1999cited by this paper
• Genomic structure of the human M6P/IGF2 receptor

  1999cited by this paper
• Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis

  1999cited by this paper
• Normal growth and development in the absence of hepatic insulin-like growth factor I.

  1999cited by this paper
• Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth*

  1998cited by this paper
• Imprinted M6p/Igf2 receptor is mutated in rat liver tumors

  1998cited by this paper
• Characterization of Insulin Receptor Substrate 4 in Human Embryonic Kidney 293 Cells*

  1998cited by this paper
• Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

  1997cited by this paper
• Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.

  1997cited by this paper
• Imprinted genes in liver carcinogenesis

  1997cited by this paper
• Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors

  1996cited by this paper
• Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.

  1996cited by this paper
• Insulin Receptor Substrate 1 Overexpression in Human Hepatocellular Carcinoma Cells Prevents Transforming Growth Factor β1-induced Apoptosis

  1996cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• Interaction of p85 subunit of PI 3‐kinase with insulin and IGF‐1 receptors analysed by using the two‐hybrid system

  1995cited by this paper
• M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

  1995cited by this paper
• Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors.

  1995cited by this paper
• Insulin-like growth factor receptors: recent developments and new methodologies.

  1994cited by this paper
• The IRS-1 signaling system.

  1994cited by this paper
• of Insulin-Like Growth

  1993cited by this paper
• Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

  1993cited by this paper
• Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism

  1993cited by this paper
• Functional polymorphism in the parental imprinting of the human IGF2R gene.

  1993cited by this paper
• The insulin–like growth factor type–2 receptor gene is imprinted in the mouse but not in humans

  1993cited by this paper
• IGF-I is required for normal embryonic growth in mice.

  1993cited by this paper

• Comparative Analysis of Fennel Essential Oil and Manganese in PCOS Rat Model via modulating miR-145 Expression and Structure-Based Virtual Screening of IGF2R Protein to Address Insulin Resistance and Obesity

  2024cites this paper
• The m5C/m6A/m7G-related non-apoptotic regulatory cell death genes for the prediction of the prognosis and immune infiltration status in hepatocellular carcinoma

  2023cites this paper
• The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor.

  2022cites this paper
• The role of YAP1 in liver cancer stem cells: proven and potential mechanisms

  2022cites this paper
• Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma

  2021cites this paper
• EGF promotes DKK1 transcription in hepatocellular carcinoma by enhancing the phosphorylation and acetylation of histone H3

  2020cites this paper
• The Role of MicroRNAs in Influencing Body Growth and Development

  2020cites this paper
• Role of exosomes in pathogenesis, progression, diagnosis and treatment of hepatocellular carcinoma

  2019cites this paper
• Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis

  2019cites this paper
• Folic Acid Reduced Triglycerides Deposition in Primary Chicken Hepatocytes.

  2018cites this paper
• Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.

  2018cites this paper
• RNA-binding protein AUF1 suppresses miR-122 biogenesis by down-regulating Dicer1 in hepatocellular carcinoma

  2018cites this paper
• LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR‐24‐3p

  2018cites this paper
• Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.

  2017cites this paper
• Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.

  2017cites this paper
• Blood DNA methylation markers in potentially identified Chinese patients with hepatocellular carcinoma.

  2016cites this paper